Princeton, NJ -- May 30, 2014 -- Effective from June 1st 2014 and following approval by the US Food and Drug Administration (FDA), GE Healthcare today announced the intent to supply generators for the production of sodium pertechnetate; technetium (Tc99m) injection to its radiopharmacies in the US.
Dr. Jet Ski and Mr. Tide: Meet Japan’s Island-Hopping Physician
It is just after dawn and Dr. Keigo Yasukawa is already out on the water. His jet ski slices through ocean swells as a pristine morning settles over the Pacific Ocean. “When I’m on my jet ski out in the ocean I really feel a sense of liberation,” says Yasukawa. “It makes me feel free.”
It could be a snapshot from an exhilarating vacation, but the good doctor is not on a holiday. Instead, he uses his personal watercraft to hop from island to island in Japan’s southernmost Okinawa prefecture, making house calls to remote island communities.
These Magnets Are 140,000 Times Stronger than Earth’s Magnetic Field and Can Peer Inside Your Head
Next-generation OligoProcess system has potential to help pharmaceutical industry save time and money
CHALFONT ST. GILES, UK and FRANKFURT, GERMANY -- 13 May 2014 -- GE Healthcare Life Sciences (NYSE: GE) and German oligonucleotide manufacturer BioSpring GmbH announced today that BioSpring has selected and installed GE Healthcare Life Sciences' OligoProcess, a fully automated oligonucleotide synthesizer, as a core element of its state-of-the-art production facility in Frankfurt.